Concepedia

Chris Parker

CP

161

Publications

21.4K

Citations

60

H-Index

1985

Active since

Affiliations

Royal Marsden NHS Foundation Trust(Current)

Institute of Cancer Research

Royal Marsden Hospital

University College London

MRC Clinical Trials Unit at UCL

Chris Parker is an author at Royal Marsden NHS Foundation Trust specializing in medicine, urology, and oncology.

ORCID

Top concepts

Publications per year

1985–2025

161

Publications

161

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Sten Nilsson, Daniel Heinrich et al. · New England Journal of Medicine · 2013 · 3.3K citations

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

Hashim U. Ahmed, Ahmed El‐Shater Bosaily, Louise Brown et al. · The Lancet · 2017 · 3.1K citations · Full text

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Chris Parker, Elena Castro, Karim Fizazi et al. · Annals of Oncology · 2020 · 903 citations · Full text

, , +4

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

Silke Gillessen, Gerhardt Attard, Tomasz M. Beer et al. · European Urology · 2017 · 636 citations · Full text

Rows per page

1–5 of 161